Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 569,239
  • Shares Outstanding, K 109,469
  • Annual Sales, $ 9,860 K
  • Annual Income, $ -18,650 K
  • 60-Month Beta -0.11
  • Price/Sales 59.27
  • Price/Cash Flow N/A
  • Price/Book 14.48
Trade VXRT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.09
  • Number of Estimates 3
  • High Estimate -0.06
  • Low Estimate -0.11
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +71.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.99 +4.81%
on 10/21/20
8.67 -39.68%
on 09/23/20
-3.52 (-40.23%)
since 09/22/20
3-Month
4.51 +15.96%
on 09/02/20
14.70 -64.42%
on 07/23/20
-9.30 (-64.01%)
since 07/22/20
52-Week
0.27 +1,866.17%
on 11/22/19
17.49 -70.10%
on 07/14/20
+4.88 (+1,394.71%)
since 10/22/19

Most Recent Stories

More News
Lawsuits Filed Against VXRT, PLAN and PROG - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

VXRT : 5.32 (+2.31%)
PLAN : 59.66 (+0.96%)
PROG : 8.09 (+1.25%)
CLASS ACTION UPDATE for VXRT, PROG and TRQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / October 22, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

VXRT : 5.32 (+2.31%)
PROG : 8.09 (+1.25%)
TRQ : 0.7903 (-1.21%)
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Vaxart, Inc. (VXRT) Investors

, /PRNewswire/ -- announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Vaxart, Inc. ("Vaxart" or the "Company") (NASDAQ: VXRT) securities...

VXRT : 5.32 (+2.31%)
CLASS ACTION UPDATE for VXRT, BLNK and TRQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / October 21, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

VXRT : 5.32 (+2.31%)
BLNK : 8.45 (-1.40%)
TRQ : 0.7903 (-1.21%)
SHAREHOLDER ALERT: VXRT BLNK TRQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / October 21, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

VXRT : 5.32 (+2.31%)
BLNK : 8.45 (-1.40%)
TRQ : 0.7903 (-1.21%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VXRT, FSLY and CACC

NEW YORK, NY / ACCESSWIRE / October 20, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

VXRT : 5.32 (+2.31%)
FSLY : 79.90 (+0.82%)
CACC : 336.80 (-0.35%)
VXRT, BLNK & PLAN Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Lead Plaintiff Deadlines

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

VXRT : 5.32 (+2.31%)
BLNK : 8.45 (-1.40%)
PLAN : 59.66 (+0.96%)
LAWSUITS FILED AGAINST VXRT, FSLY and CACC - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / October 20, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

VXRT : 5.32 (+2.31%)
FSLY : 79.90 (+0.82%)
CACC : 336.80 (-0.35%)
Top Pharmaceutical Stocks To Capitalize On U.S. Vaccine Hopes

Vaccine progress is bringing these pharmaceutical stocks back onto investors’ radar.

PFE : 37.33 (+0.67%)
VXRT : 5.32 (+2.31%)
BMY : 60.34 (+0.52%)
BIIB : 264.45 (-1.66%)
BNTX : 85.75 (-2.25%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VXRT, BLNK and CACC

NEW YORK, NY / ACCESSWIRE / October 19, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

VXRT : 5.32 (+2.31%)
BLNK : 8.45 (-1.40%)
CACC : 336.80 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

2nd Resistance Point 5.54
1st Resistance Point 5.37
Last Price 5.32
1st Support Level 5.01
2nd Support Level 4.82

See More

52-Week High 17.49
Fibonacci 61.8% 10.91
Fibonacci 50% 8.88
Fibonacci 38.2% 6.85
Last Price 5.32
52-Week Low 0.27

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar